Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting

Neel R. Gandhi, Jason R. Andrews, James C.m. Brust, Romualde Montreuil, Darren Weissman, Moonseong Heo, Anthony P. Moll, Gerald Friedland, N. Sarita ShahThe International Journal of Tuberculosis and Lung Disease 2011 · DOI

Abstract

Mortality due to MDR- and XDR-TB was associated with greater degree of immunosuppression and drug resistance. Efforts to reduce mortality must focus on preventing the amplification of resistance by strengthening TB treatment programs, as well as reducing the pool of immunosuppressed HIV-infected patients through aggressive HIV testing and ART initiation.
BibTeX
@article{gandhi2011risk,
  author = {Neel R. Gandhi and Jason R. Andrews and James C.M. Brust and Romualde Montreuil and Darren Weissman and Moonseong Heo and Anthony P. Moll and Gerald Friedland and N. Sarita Shah},
  title = {{Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting}},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2011},
  doi = {10.5588/ijtld.11.0153},
}

Loading related content...

Figure